Literature DB >> 316287

[Noncontact detection of intraocular lesions by means of a gamma scintillation camera].

H Bockslaff, D Dausch, H Bornemann, L Stöppler, H Hundeshagen.   

Abstract

A gamma scintillation camera is used for noncontact detection of intraocular mass lesions. A double aperture pinhole collimator was designed for this special application. The collimator projects a magnified image of the radioactivity present in each eye onto the detector crystal of the camera. Details of the collimator design are described. The image-making properties of a double aperture pinhole collimator for ocular scintigraphy in regard to resolution and response were studied and demonstrated by phantom experiments. So far we have studied 50 cases with this new nuclear medicine procedure, using mainly technetium-pertechnetate as the radioindicator. Case histories and records of some typical results are presented. Better designed radiopharmaceuticals with appropriate tumor-seeking properties should be developed. Labeled melanin precursors are promising for detection of these lesions.

Entities:  

Mesh:

Year:  1979        PMID: 316287     DOI: 10.1007/bf02387424

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  23 in total

1.  Quinoline analog labeled with iodine 123 in melanoma detection.

Authors:  S Packer; C Redvanly; R M Lambrecht; A P Wolf; H L Atkins
Journal:  Arch Ophthalmol       Date:  1975-07

2.  [Use of labelled molecules in the diagnosis and surveillance of melanomas].

Authors:  N Safi; P Blanquet
Journal:  Biomedicine       Date:  1973-03-20

3.  A new method of evaluating lacrimal drainage.

Authors:  R M Rossomondo; W H Carlton; J H Trueblood; R P Thomas
Journal:  Arch Ophthalmol       Date:  1972-11

4.  Clinical evaluation of microscintigraphy of the lacrimal drainage apparatus.

Authors:  W H Carlton; J H Trueblood; R M Rossomondo
Journal:  J Nucl Med       Date:  1973-02       Impact factor: 10.057

5.  [Results of nuclear medicine studies in melanoblastoma of the eye as compared to the histological findings].

Authors:  M W Strötges
Journal:  Radiobiol Radiother (Berl)       Date:  1971

6.  Tissue and tumor concentrations of technetium 99m as pertechnetate.

Authors:  F S Mishkin; I C Reese
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-09

7.  [Pigmented nevi of the choroid and ciliary bodies. A clinical and histopathological study].

Authors:  G Naumann
Journal:  Adv Ophthalmol       Date:  1970

8.  Problems in the differential diagnosis of choroidal nevi and malignant melanomas. The XXXIII Edward Jackson Memorial Lecture.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1977-03       Impact factor: 5.258

9.  [Clinically unsuspected malignant melanomas of the posterior uvea (author's transl)].

Authors:  H E Völcker; G O Naumann
Journal:  Klin Monbl Augenheilkd       Date:  1976-03       Impact factor: 0.700

10.  [The diagnostic value of the 67gallium-scintigraphy in malignant melanoma (author's transl)].

Authors:  H H Peter; A Brase; P B Meyer; A Gisbertz; D Dragojevic
Journal:  Langenbecks Arch Chir       Date:  1975-06-09
View more
  4 in total

1.  The reliability of radioactive phosphorus (32P) in the diagnosis of intraocular tumors; experience with 912 patients.

Authors:  P K Lommatzsch; H J Correns; J M Rudolph; U Seiffarth; H Deckart
Journal:  Doc Ophthalmol       Date:  1984-02-29       Impact factor: 2.379

2.  Radiation doses to the eye lens from ocular tumour seeking radiopharmaceuticals.

Authors:  R Weinreich; H Bockslaff
Journal:  Eur J Nucl Med       Date:  1983

3.  Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine.

Authors:  H Bockslaff; M Spitznas; I Hahn; G Kloster
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

4.  Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results.

Authors:  H Bockslaff; G Kloster; D Dausch; K Schad; H Hundeshagen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.